Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer
Recruiting
- Conditions
- Endometrial Cancer
- Registration Number
- NCT05807672
- Brief Summary
In this context, the aim of this study is to investigate the role of MRF in endometrial cancer. Several applications are possible. Firstly, T1-, T2- and DWI-mappings can be associated to molecular risk group classification, in order to stratify patients' risk without recurring to surgery. MRF parameters can be also correlated to prognosis, both in terms of disease-free survival (DFS) and overall survival (OS).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
- Patients with biopsy-proven endometrial cancer;
- Women aged > 18 years old;
- Signed Informed consent.
Read More
Exclusion Criteria
- Previous history of neoplasm;
- Concurrent malignancies at other sites.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association between T1-, T2- and diffusion-mappings and risk group classification 3 months
- Secondary Outcome Measures
Name Time Method Diagnostic accuracy of T1-,T2- and diffusion-mappings deriving from MRF in myometrial invasion detection 3 months Evaluation of Radiomic and Radiogenomic models to predict recurrence in early stage EC and to predict DFS and OS 3 years Correlation between T1-, T2- and diffusion mappings and DFS and OS 3 years Diagnostic accuracy of T1-,T2- and diffusion-mappings and pathological nodal involvement 3 months
Trial Locations
- Locations (1)
Fondazione Policlinico Universitaro "A. Gemelli" IRCCS
🇮🇹Roma, Italy